532 related articles for article (PubMed ID: 27184880)
1. Serum and Urinary Interferon-Gamma-Inducible Protein 10 in Lupus Nephritis.
El-Gohary A; Hegazy A; Abbas M; Kamel N; Nasef SI
J Clin Lab Anal; 2016 Nov; 30(6):1135-1138. PubMed ID: 27184880
[TBL] [Abstract][Full Text] [Related]
2. Urinary CXCL-10/IP-10 and MCP-1 as markers to assess activity of lupus nephritis.
Abujam B; Cheekatla S; Aggarwal A
Lupus; 2013 May; 22(6):614-23. PubMed ID: 23629827
[TBL] [Abstract][Full Text] [Related]
3. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY
Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
[TBL] [Abstract][Full Text] [Related]
4. Urinary angiostatin, CXCL4 and VCAM-1 as biomarkers of lupus nephritis.
Mok CC; Soliman S; Ho LY; Mohamed FA; Mohamed FI; Mohan C
Arthritis Res Ther; 2018 Jan; 20(1):6. PubMed ID: 29325582
[TBL] [Abstract][Full Text] [Related]
5. Interferon-Inducible Protein 10 and Disease Activity in Systemic Lupus Erythematosus and Lupus Nephritis: A Systematic Review and Meta-Analysis.
Puapatanakul P; Chansritrakul S; Susantitaphong P; Ueaphongsukkit T; Eiam-Ong S; Praditpornsilpa K; Kittanamongkolchai W; Avihingsanon Y
Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31597273
[TBL] [Abstract][Full Text] [Related]
6. Serum IP-10 is useful for identifying renal and overall disease activity in pediatric systemic lupus erythematosus.
Zhang CX; Cai L; Shao K; Wu J; Zhou W; Cao LF; Chen TX
Pediatr Nephrol; 2018 May; 33(5):837-845. PubMed ID: 29264699
[TBL] [Abstract][Full Text] [Related]
7. Urinary CXCL10: a marker of nephritis in lupus patients.
Marie MA; Abu Khalil RE; Habib HM
Reumatismo; 2014 Mar; 65(6):292-7. PubMed ID: 24705033
[TBL] [Abstract][Full Text] [Related]
8. Serum and urinary galectin-9 and C-X-C motif chemokine ligand 10.
Mehta P; Singh P; Aggarwal A
Lupus; 2022 Apr; 31(4):482-487. PubMed ID: 35245170
[TBL] [Abstract][Full Text] [Related]
9. Serum Levels of CXCL10 and Vitamin D in Patients with Lupus Nephritis.
Abediazar S; Jafari-Nakhjavani M; Ghorbanihaghjo A; Shekarchi M; Zununi Vahed S
Iran J Kidney Dis; 2019 Nov; 13(6):389-397. PubMed ID: 31880585
[TBL] [Abstract][Full Text] [Related]
10. Serum uric acid as a predictor for nephritis in Egyptian patients with systemic lupus erythematosus.
Hafez EA; Hassan SAE; Teama MAM; Badr FM
Lupus; 2021 Mar; 30(3):378-384. PubMed ID: 33323012
[TBL] [Abstract][Full Text] [Related]
11. Identification of Low-Abundance Urinary Biomarkers in Lupus Nephritis Using Electrochemiluminescence Immunoassays.
Stanley S; Mok CC; Vanarsa K; Habazi D; Li J; Pedroza C; Saxena R; Mohan C
Arthritis Rheumatol; 2019 May; 71(5):744-755. PubMed ID: 30618193
[TBL] [Abstract][Full Text] [Related]
12. Urinary C3d is elevated in patients with active Lupus nephritis and a fall in its level after 3 months predicts response at 6 months on follow up.
Ganguly S; Majumder S; Kumar S; Gupta R; Muhammed H; Shobha V; Aggarwal A; Misra R
Lupus; 2020 Nov; 29(13):1800-1806. PubMed ID: 32807020
[TBL] [Abstract][Full Text] [Related]
13. Estimation of monocyte-chemoattractantprotein-1 (Mcp-1) level in patients with lupus nephritis.
Alzawawy A; Zohary M; Ablordiny M; Eldalie M
Int J Rheum Dis; 2009 Dec; 12(4):311-8. PubMed ID: 20374368
[TBL] [Abstract][Full Text] [Related]
14. Anti-C1q antibodies in lupus nephritis and their correlation with the disease activity.
Emad G; Al-Barshomy SM
Saudi J Kidney Dis Transpl; 2020; 31(2):342-352. PubMed ID: 32394906
[TBL] [Abstract][Full Text] [Related]
15. Elevated serum levels of syndecan-1 are associated with renal involvement in patients with systemic lupus erythematosus.
Kim KJ; Kim JY; Baek IW; Kim WU; Cho CS
J Rheumatol; 2015 Feb; 42(2):202-9. PubMed ID: 25512478
[TBL] [Abstract][Full Text] [Related]
16. Increased urinary interleukin 22 binding protein levels correlate with lupus nephritis activity.
Yang X; Gao Y; Wang H; Zhao X; Gong X; Wang Q; Zhang X
J Rheumatol; 2014 Sep; 41(9):1793-800. PubMed ID: 25086075
[TBL] [Abstract][Full Text] [Related]
17. The role of urinary neutrophil gelatinase-associated lipocalin in lupus nephritis.
Alharazy SM; Kong NC; Mohd M; Shah SA; Abdul Gafor AH; Ba'in A
Clin Chim Acta; 2013 Oct; 425():163-8. PubMed ID: 23954775
[TBL] [Abstract][Full Text] [Related]
18. Serum TWEAK as a biomarker for disease activity of systemic lupus erythematosus.
Choe JY; Kim SK
Inflamm Res; 2016 Jun; 65(6):479-88. PubMed ID: 26921306
[TBL] [Abstract][Full Text] [Related]
19. Urine sVCAM-1 and sICAM-1 levels are elevated in lupus nephritis.
Howe HS; Kong KO; Thong BY; Law WG; Chia FL; Lian TY; Lau TC; Chng HH; Leung BP
Int J Rheum Dis; 2012 Feb; 15(1):13-6. PubMed ID: 22324942
[TBL] [Abstract][Full Text] [Related]
20. Urinary neutrophil gelatinase-associated lipocalin and monocyte chemoattractant protein 1 as biomarkers for lupus nephritis in Colombian SLE patients.
Gómez-Puerta JA; Ortiz-Reyes B; Urrego T; Vanegas-García AL; Muñoz CH; González LA; Cervera R; Vásquez G
Lupus; 2018 Apr; 27(4):637-646. PubMed ID: 29073812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]